One of the Listed Companies Central Pharmaceuticals Limited discloses its financial reports for the first quarter, (July-September’22) This source is known from DSE.
The company’s earnings per share (EPS) loss of Tk 0.08 paisa in Q1 of the current financial year. EPS was loss of Tk 0.08 paisa during the same period last year. As of September 30, 2022, the net asset value (NAVPS) was Tk 5.88 paisa.
/NR
Share this
